BNP Paribas Financial Markets Acquires Shares of 169,366 FIGS, Inc. (NYSE:FIGS)

BNP Paribas Financial Markets acquired a new stake in shares of FIGS, Inc. (NYSE:FIGS) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 169,366 shares of the company’s stock, valued at approximately $1,048,000. BNP Paribas Financial Markets owned about 0.10% of FIGS as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Sugar Maple Asset Management LLC purchased a new stake in shares of FIGS during the fourth quarter valued at $43,000. Blue Trust Inc. boosted its stake in shares of FIGS by 395.3% during the fourth quarter. Blue Trust Inc. now owns 7,642 shares of the company’s stock valued at $47,000 after purchasing an additional 6,099 shares during the period. Stifel Financial Corp purchased a new stake in shares of FIGS during the fourth quarter valued at $70,000. Cibc World Markets Corp purchased a new stake in shares of FIGS during the fourth quarter valued at $75,000. Finally, Senvest Management LLC purchased a new stake in shares of FIGS during the fourth quarter valued at $84,000. Institutional investors own 92.21% of the company’s stock.

FIGS Stock Performance

Shares of FIGS stock opened at $4.59 on Wednesday. The stock’s fifty day moving average is $4.34 and its two-hundred day moving average is $5.09. The firm has a market capitalization of $745.97 million, a P/E ratio of 76.50, a PEG ratio of 31.62 and a beta of 1.20. FIGS, Inc. has a fifty-two week low of $3.57 and a fifty-two week high of $7.06.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on FIGS shares. Telsey Advisory Group reaffirmed a “market perform” rating and issued a $5.00 price objective on shares of FIGS in a research note on Tuesday, May 13th. The Goldman Sachs Group decreased their price target on shares of FIGS from $4.25 to $3.75 and set a “sell” rating for the company in a research report on Tuesday, April 22nd. Barclays reissued a “positive” rating on shares of FIGS in a research report on Tuesday, May 13th. Finally, Morgan Stanley decreased their price target on shares of FIGS from $4.75 to $4.25 and set an “equal weight” rating for the company in a research report on Thursday, April 17th.

FIGS Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.